A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer
Web of Science
AuthorThompson, E; Dragovic, RL; Stephenson, SA; Eccles, DM; Campbell, IG; Dobrovic, A
Source TitleBMC Cancer
AffiliationSurgery (Austin & Northern Health)
Document TypeJournal Article
CitationsThompson, E., Dragovic, R. L., Stephenson, S. A., Eccles, D. M., Campbell, I. G. & Dobrovic, A. (2005). A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer. BMC CANCER, 5 (1), https://doi.org/10.1186/1471-2407-5-43.
Access StatusOpen Access
UNLABELLED: The FANCA gene is one of the genes in which mutations lead to Fanconi anaemia, a rare autosomal recessive disorder characterised by congenital abnormalities, bone marrow failure, and predisposition to malignancy. FANCA is also a potential breast and ovarian cancer susceptibility gene. A novel allele was identified which has a tandem duplication of a 13 base pair sequence in the promoter region. METHODS: We screened germline DNA from 352 breast cancer patients, 390 ovarian cancer patients and 256 normal controls to determine if the presence of either of these two alleles was associated with an increased risk of breast or ovarian cancer. RESULTS: The duplication allele had a frequency of 0.34 in the normal controls. There was a non-significant decrease in the frequency of the duplication allele in breast cancer patients. The frequency of the duplication allele was significantly decreased in ovarian cancer patients. However, when malignant and benign tumours were considered separately, the decrease was only significant in benign tumours. CONCLUSION: The allele with the tandem duplication does not appear to modify breast cancer risk but may act as a low penetrance protective allele for ovarian cancer.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References